company

PROPHYLAXIA SIGNS AS

6392 VIKEBUKT

Return on Equity
44,25 %
Current Ratio
4,98
Debt-to-Equity Ratio
−1,46
Key figures (NOK)2022
Revenue1 596 000
Net Income−1 712 000
Total Assets2 221 000
Total Equity−3 869 000
Income (NOK)2022
Revenue1 596 000
Expenditure270 000
Operating Profit214 000
Financial Income0
Financial Costs1 927 000
Financial Balance−1 927 000
Earnings Before Tax−1 712 000
Tax0
Net Income−1 712 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets2 221 000
Total Assets2 221 000
Total Retained Equity−12 353 000
Total Equity−3 869 000
Total Long-Term Debt5 644 000
Total Current Debt446 000
Total Equity and Debt2 221 000
Cash flow (NOK)2022
Sales Income1 596 000
Other Income0
Revenue1 596 000
Cost of Goods Sold9 000
Salary Costs0
Depreciation0
Impairment0
Expenditure270 000
Operating Profit214 000
Financial Income0
Financial Costs1 927 000
Financial Balance−1 927 000
Dividends0
Net Income−1 712 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock1 141 000
Total Investments0
Cash, Bank608 000
Total Current Assets2 221 000
Total Assets2 221 000
Total Equity−3 869 000
Short-Term Group Debt0
Total Long-Term Debt5 644 000
Creditors24 000
Unpaid Taxes90 000
Dividends0
Other Current Debt332 000
Total Current Debt446 000
Total Equity and Debt2 221 000
Financial indicators2022
Return on Equity44,25 %
Debt-to-Equity Ratio−1,46
Operating Profit Margin13,41 %
Current Ratio4,98
Quick Ratio−3,2
Equity Ratio−1,74
Gross Profit Margin99,44 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English